The structure and function of the S1P1 receptor
|
journal
|
July 2013 |
Phosphorylation of the Immunomodulatory Drug FTY720 by Sphingosine Kinases
|
journal
|
November 2003 |
Alteration of Lymphocyte Trafficking by Sphingosine-1-Phosphate Receptor Agonists
|
journal
|
March 2002 |
Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis
|
journal
|
October 2010 |
Immune Cell Regulation and Cardiovascular Effects of Sphingosine 1-Phosphate Receptor Agonists in Rodents Are Mediated via Distinct Receptor Subtypes
|
journal
|
January 2004 |
The Clinically-tested S1P Receptor Agonists, FTY720 and BAF312, Demonstrate Subtype-Specific Bradycardia (S1P1) and Hypertension (S1P3) in Rat
|
journal
|
December 2012 |
The selective sphingosine 1‐phosphate receptor modulator BAF312 redirects lymphocyte distribution and has species‐specific effects on heart rate
|
journal
|
October 2012 |
Sphingosine 1-Phosphate (S1P) Regulates Vascular Contraction via S1P 3 Receptor: Investigation Based on a New S1P 3 Receptor Antagonist
|
journal
|
January 2010 |
Induction of Antiproliferative Connective Tissue Growth Factor Expression in Wilms' Tumor Cells by Sphingosine-1-Phosphate Receptor 2
|
journal
|
October 2008 |
Importance of Sphingosine Kinase (SphK) as a Target in Developing Cancer Therapeutics and Recent Developments in the Synthesis of Novel SphK Inhibitors: Miniperspective
|
journal
|
February 2014 |
Sphingosine-1-phosphate mobilizes osteoclast precursors and regulates bone homeostasis
|
journal
|
February 2009 |
Rituximab combination therapy in relapsing multiple sclerosis
|
journal
|
October 2012 |
Oral treatment with SEW2871, a sphingosine-1-phosphate type 1 receptor agonist, ameliorates experimental colitis in interleukin-10 gene deficient mice: SEW2871 ameliorates colitis in IL-10-/- mice
|
journal
|
June 2014 |
IL-1R Signaling within the Central Nervous System Regulates CXCL12 Expression at the Blood-Brain Barrier and Disease Severity during Experimental Autoimmune Encephalomyelitis
|
journal
|
June 2009 |
Pharmacological Modulation of Peripheral T and B Lymphocytes by a Selective Sphingosine 1-Phosphate Receptor-1 Modulator
|
journal
|
July 2012 |
Targeting Sphingosine 1-phosphate (S1P) Levels and S1P Receptor Functions for Therapeutic Immune Interventions
|
journal
|
January 2010 |
The blood–brain barrier, chemokines and multiple sclerosis
|
journal
|
February 2011 |
The prediction of human response to ONO-4641, a sphingosine 1-phosphate receptor modulator, from preclinical data based on pharmacokinetic-pharmacodynamic modeling
|
journal
|
July 2010 |
Pathological Expression of CXCL12 at the Blood-Brain Barrier Correlates with Severity of Multiple Sclerosis
|
journal
|
March 2008 |
Pharmacologic Targeting of Sphingosine-1-Phosphate Receptor 1 Improves the Renal Microcirculation during Sepsis in the Mouse
|
journal
|
October 2014 |
The Role of Imaging in Proof of Concept for CNS Drug Discovery and Development
|
journal
|
October 2008 |
Discussion of targeting proteins in vivo: in vitro guidelines
|
journal
|
May 2006 |
Targeting proteins in vivo: in vitro guidelines
|
journal
|
February 2006 |
BZM055, an Iodinated Radiotracer Candidate for PET and SPECT Imaging of Myelin and FTY720 Brain Distribution
|
journal
|
January 2011 |
Synthesis of fluorinated analogues of sphingosine-1-phosphate antagonists as potential radiotracers for molecular imaging using positron emission tomography
|
journal
|
October 2014 |
Synthesis and Evaluation of Fluorinated Fingolimod (FTY720) Analogues for Sphingosine-1-Phosphate Receptor Molecular Imaging by Positron Emission Tomography
|
journal
|
April 2015 |
A potent and selective C-11 labeled PET tracer for imaging sphingosine-1-phosphate receptor 2 in the CNS demonstrates sexually dimorphic expression
|
journal
|
January 2015 |
A promising carbon-11-labeled sphingosine-1-phosphate receptor 1-specific PET tracer for imaging vascular injury
|
journal
|
February 2016 |
PET Imaging Study of S1PR1 Expression in a Rat Model of Multiple Sclerosis
|
journal
|
March 2016 |
Identification of benzoxazole analogs as novel, S1P3 sparing S1P1 agonists
|
journal
|
June 2012 |
Pharmacophore-Based Design of Novel Oxadiazoles as Selective Sphingosine-1-phosphate (S1P) Receptor Agonists with in vivo Efficacy
|
journal
|
March 2015 |
Discovery of Potent 3,5-Diphenyl-1,2,4-oxadiazole Sphingosine-1-phosphate-1 (S1P 1 ) Receptor Agonists with Exceptional Selectivity against S1P 2 and S1P 3
|
journal
|
September 2005 |
A practical process for the preparation of [32P]S1P and binding assay for S1P receptor ligands
|
journal
|
August 2015 |
Sphingosine 1-Phosphate (S1P) Receptor Subtypes S1P1 and S1P3, Respectively, Regulate Lymphocyte Recirculation and Heart Rate
|
journal
|
April 2004 |
Radiolabeled isatin binding to caspase-3 activation induced by anti-Fas antibody
|
journal
|
January 2012 |
Sphingosine-1-phosphate receptors control B-cell migration through signaling components associated with primary immunodeficiencies, chronic lymphocytic leukemia, and multiple sclerosis
|
journal
|
August 2014 |
Dysregulation of sphingosine 1 phosphate receptor-1 (S1P1) signaling and regulatory lymphocyte-dependent immunosuppression in a model of post-fingolimod MS rebound
|
journal
|
November 2015 |
Parallel synthesis of 1,2,4-oxadiazoles from carboxylic acids using an improved, uronium-based, activation
|
journal
|
February 2001 |
Determination of lipophilicity and its use as a predictor of blood–brain barrier penetration of molecular imaging agents
|
journal
|
December 2003 |
Efficacy and immunomodulatory actions of ONO-4641, a novel selective agonist for sphingosine 1-phosphate receptors 1 and 5, in preclinical models of multiple sclerosis: ONO-4641: a S1P 1 and S1P 5 selective agonist
|
journal
|
December 2012 |
Crystal Structure of a Lipid G Protein-Coupled Receptor
|
journal
|
February 2012 |
Protective Effects of Sphingosine 1-Phosphate in Murine Endotoxin-induced Inflammatory Lung Injury
|
journal
|
June 2004 |
Sphingosine-1-phosphate receptor 1 reporter mice reveal receptor activation sites in vivo
|
journal
|
March 2014 |
Full Pharmacological Efficacy of a Novel S1P 1 Agonist That Does Not Require S1P-Like Headgroup Interactions
|
journal
|
August 2008 |
Quantification of Skeletal Blood Flow and Fluoride Metabolism in Rats using PET in a Pre-Clinical Stress Fracture Model
|
journal
|
July 2011 |
Assessment of hepatic blood flow by PET with 15O water: Correlation between per-rectal portal scintigraphy with 99Tcm-pertechnetate and scintigraphy with 99Tcm-GSA
|
journal
|
January 2000 |
Use of Tc-99m Mebrofenin as a Clinical Probe to Assess Altered Hepatobiliary Transport: Integration of In Vitro, Pharmacokinetic Modeling, and Simulation Studies
|
journal
|
May 2008 |
Systemic and local release of inflammatory cytokines regulates hepatobiliary excretion of 99mTc-mebrofenin
|
journal
|
January 2008 |
Ligand-Binding Pocket Shape Differences between Sphingosine 1-Phosphate (S1P) Receptors S1P 1 and S1P 3 Determine Efficiency of Chemical Probe Identification by Ultrahigh-Throughput Screening
|
journal
|
July 2008 |
Decoding cell death signals in liver inflammation
|
journal
|
September 2013 |
The sphingosine kinase 1 and S1P1 axis specifically counteracts LPS-induced IL-12p70 production in immune cells of the spleen
|
journal
|
May 2011 |
Design and Synthesis of 2-Amino-4-methylpyridine Analogues as Inhibitors for Inducible Nitric Oxide Synthase and in Vivo Evaluation of [ 18 F]6-(2-Fluoropropyl)-4-methyl-pyridin-2-amine as a Potential PET Tracer for Inducible Nitric Oxide Synthase
|
journal
|
March 2009 |